Clinical Trial Update: Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis

View source ↗

Summary

This clinical trial update investigates whether the 5-HT7 receptor plays a role in inflammatory mechanisms in multiple sclerosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: Healthy, Multiple Sclerosis | Status: COMPLETED